Mabion S.A. (WSE:MAB)
Poland · Delayed Price · Currency is PLN 7.85
+0.13 (1.68%)
Sep 4, 2026, 5:01 PM CET
Mabion Market Cap
Mabion has a market cap or net worth of 126.87 million as of September 4, 2026. Its market cap has decreased by -9.35% in one year.
Market Cap
126.87M
Enterprise Value
145.26M
Revenue
17.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.85
ChartMarket Cap Chart
Since August 10, 2010, Mabion's market cap has increased from 93.01M to 126.87M, an increase of 36.41%. That is a compound annual growth rate of 1.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 126.87M | 12.46% |
| Dec 30, 2025 | 112.81M | -21.57% |
| Dec 30, 2024 | 143.84M | -50.96% |
| Dec 29, 2023 | 293.35M | -13.57% |
| Dec 30, 2022 | 339.41M | -65.63% |
| Dec 30, 2021 | 987.46M | 246.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 497.56M |
| Captor Therapeutics Spolka Akcyjna | 454.27M |
| Bioceltix | 438.15M |
| Ryvu Therapeutics | 392.58M |
| BIOTON | 323.71M |
| Synthaverse | 222.39M |
| Molecure | 132.68M |
| Poltreg | 130.75M |